Your search returned 3 results.

Sort
Results
1.
Radical excision for retroperitoneal soft tissue sarcoma: A national propensity-matched outcomes analysis. MedStar authors:
  • Al-Refaie, Waddah B
  • Chan, Kitty
  • Nigam, Aradhya
  • Shara, Nawar M
  • Villano, Anthony M
  • Zeymo, Alexander
PMID:
  • 32709488
Year: 2020
Citation:
  • Surgery. 168(5):831-837, 2020 11.
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
Department:
  • Surgery/General Surgery
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Al-Refaie WB, Chan KS, Nigam A, Shara N, Unger KR, Villano AM, Zeymo A
2.
Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab. MedStar authors:
  • Priebat, Dennis A
PMID:
  • 31900276
Year: 2020
Citation:
  • Clinical Cancer Research. 26(6):1258-1266, 2020 03 15.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Attia S, Bolejack V, Burgess M, Davis LE, Hu J, Keung EZ, Lazar AJ, Movva S, Okuno S, Parra Cuentas E, Priebat DA, Reed DR, Reinke DK, Reuben A, Riedel RF, Rodrigues-Canales J, Roland CL, Salazar R, Schuetze SM, Tawbi HA, Van Tine BA, Wang WL, Wargo JA
3.
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial. MedStar authors:
  • Priebat, Dennis A
PMID:
  • 28988646
Year: 2017
Citation:
  • Lancet Oncology. 18(11):1493-1501, 2017 Nov
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Attia S, Baker LH, Bolejack V, Burgess M, Butterfield LH, Crowley J, D'Angelo S, Davis LE, Hu J, Lazar AJ, Maki RG, Movva S, Okuno SH, Patel S, Priebat DA, Reed DR, Reinke D, Riedel RF, Rodriguez-Canales J, Salazar R, Schuetze SM, Tawbi HA, Van Tine BA, Wistuba II
Pages

Powered by Koha